| Update on meningiomas S Saraf, BJ McCarthy, JL Villano The oncologist 16 (11), 1604-1613, 2011 | 232 | 2011 |
| Differences in the clinical and genotypic presentation of sickle cell disease around the world SL Saraf, RE Molokie, M Nouraie, CA Sable, L Luchtman-Jones, ... Paediatric respiratory reviews 15 (1), 4-12, 2014 | 174 | 2014 |
| Nonmyeloablative stem cell transplantation with alemtuzumab/low-dose irradiation to cure and improve the quality of life of adults with sickle cell disease SL Saraf, AL Oh, PR Patel, Y Jalundhwala, K Sweiss, M Koshy, ... Biology of Blood and Marrow Transplantation 22 (3), 441-448, 2016 | 136 | 2016 |
| COVID‐19 infection in patients with sickle cell disease FA Hussain, FU Njoku, SL Saraf, RE Molokie, VR Gordeuk, J Han British journal of haematology 189 (5), 851, 2020 | 119 | 2020 |
| Kidney disease among patients with sickle cell disease, hemoglobin SS and SC P Drawz, S Ayyappan, M Nouraie, S Saraf, V Gordeuk, T Hostetter, ... Clinical Journal of the American Society of Nephrology 11 (2), 207-215, 2016 | 107 | 2016 |
| Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia SL Saraf, X Zhang, T Kanias, JP Lash, RE Molokie, B Oza, C Lai, ... British journal of haematology 164 (5), 729-739, 2014 | 103 | 2014 |
| Age-related differences in disease characteristics and clinical outcomes in polycythemia vera BL Stein, S Saraf, U Sobol, A Halpern, J Shammo, D Rondelli, L Michaelis, ... Leukemia & lymphoma 54 (9), 1989-1995, 2013 | 86 | 2013 |
| Feasibility of implementing a comprehensive warfarin pharmacogenetics service EA Nutescu, K Drozda, AP Bress, WL Galanter, J Stevenson, TD Stamos, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (11 …, 2013 | 80 | 2013 |
| Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy SL Saraf, X Zhang, B Shah, T Kanias, KP Gudehithlu, R Kittles, ... Haematologica 100 (10), 1275, 2015 | 75 | 2015 |
| Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in … GMT Guilcher, TH Truong, SL Saraf, JJ Joseph, D Rondelli, MM Hsieh Seminars in hematology 55 (2), 87-93, 2018 | 65 | 2018 |
| Clinical effectiveness of decitabine in severe sickle cell disease Y Saunthararajah, R Molokie, S Saraf, S Sidhwani, M Gowhari, S Vara, ... British journal of haematology 141 (1), 126-129, 2008 | 63 | 2008 |
| Metabolomic markers of kidney function decline in patients with diabetes: evidence from the chronic renal insufficiency cohort (CRIC) study B Kwan, T Fuhrer, J Zhang, M Darshi, B Van Espen, D Montemayor, ... American Journal of Kidney Diseases 76 (4), 511-520, 2020 | 57 | 2020 |
| Haploidentical peripheral blood stem cell transplantation demonstrates stable engraftment in adults with sickle cell disease SL Saraf, AL Oh, PR Patel, K Sweiss, M Koshy, S Campbell-Lee, ... Biology of Blood and Marrow Transplantation 24 (8), 1759-1765, 2018 | 56 | 2018 |
| Characterization of opioid use in sickle cell disease J Han, J Zhou, SL Saraf, VR Gordeuk, GS Calip Pharmacoepidemiology and drug safety 27 (5), 479-486, 2018 | 52 | 2018 |
| APOL1, α-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia SL Saraf, BN Shah, X Zhang, J Han, BO Tayo, T Abbasi, A Ostrower, ... Haematologica 102 (1), e1, 2017 | 50 | 2017 |
| Combination of linear accelerator–based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: A phase I study P Patel, B Aydogan, M Koshy, D Mahmud, A Oh, SL Saraf, JG Quigley, ... Biology of Blood and Marrow Transplantation 20 (12), 2034-2041, 2014 | 47 | 2014 |
| Non‐myeloablative human leukocyte antigen‐matched related donor transplantation in sickle cell disease: outcomes from three independent centres M Alzahrani, M Damlaj, N Jeffries, B Alahmari, A Singh, D Rondelli, ... British journal of haematology 192 (4), 761-768, 2021 | 46 | 2021 |
| Losartan for the nephropathy of sickle cell anemia: A phase‐2, multicenter trial CT Quinn, SL Saraf, VR Gordeuk, CD Fitzhugh, SE Creary, P Bodas, ... American journal of hematology 92 (9), E520-E528, 2017 | 43 | 2017 |
| Hypoxic response contributes to altered gene expression and precapillary pulmonary hypertension in patients with sickle cell disease X Zhang, W Zhang, SF Ma, AA Desai, S Saraf, G Miasniakova, ... Circulation 129 (16), 1650-1658, 2014 | 43 | 2014 |
| Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study O Niss, A Lane, MR Asnani, ME Yee, A Raj, S Creary, C Fitzhugh, ... Blood advances 4 (7), 1501-1511, 2020 | 41 | 2020 |
